ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 346098 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 346098; 2) Community: the network communities that were significantly associated with the response to NSC 346098; 3) Molecule: the relationships between components within communities and NSC 346098; 4) MDR: the compounds that were significantly associated with the NSC 346098.

NSC Compound Enrichment Correlation
NSC 684409 18-Norestr-4-en-3-one, 17-ethynyl-13-ethyl- 17.beta.-hydroxy-,2-[(9,10-dihydro-10-oxo-4-acridinyl)carbonyl]hydrazone 0.029142074732756 0.039216719
NSC 686551 Null 0.029142074732756 0.077289118
NSC 688228 Null 0.029142074732756 0.1629381
NSC 693248 Null 0.029142074732756 0.1607575
NSC 703784 L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride 0.029142074732756 0.16039419
NSC 715407 Null 0.029142074732756 0.36489503
NSC 718781 Erlotinib hydrochloride 0.029142074732756 -0.39485989
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.029142074732756 0.57819953
NSC 750050 Null 0.029142074732756 0.29981927
NSC 753427 2.5-anhydro-1-(3,4,5-trimethoxyphenyl)-1-[3-hydroxy-4-methoxyphenyl]-1-desoxy-3.4:6.7-di-O-isopropylidene-L-glucohept-1-enitol 0.029142074732756 0.073346856
Total:77  Current:50    [First] [Prev] [Next] [Last]